Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.
- DOI
- 10.3324/haematol.2024.286325
- Published
- 2025 May 1
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2024.286325,
title = {Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.},
author = {Dragani M and Ansuinelli M and Papayannidis C and Fracchiolla N and Cardinali V and Cedrone M and Guolo F and Perrone S and Salutari P and Todisco E and Foà R and Chiaretti S},
year = {2025},
journal = {Haematologica},
doi = {10.3324/haematol.2024.286325},
url = {https://doi.org/10.3324/haematol.2024.286325}
}RIS
TY - JOUR TI - Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study. AU - Dragani M AU - Ansuinelli M AU - Papayannidis C AU - Fracchiolla N AU - Cardinali V AU - Cedrone M AU - Guolo F AU - Perrone S AU - Salutari P AU - Todisco E AU - Foà R AU - Chiaretti S PY - 2025 JO - Haematologica DO - 10.3324/haematol.2024.286325 UR - https://doi.org/10.3324/haematol.2024.286325 ER -
APA
M, D., M, A., C, P., N, F., V, C., M, C., F, G., S, P., P, S., E, T., R, F., & S, C. (2025). Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.. Haematologica. https://doi.org/10.3324/haematol.2024.286325
Source records
- pubmed · retrieved 2026-09-27T06:43:38.406Z